Shopping Cart
- Remove All
- Your shopping cart is currently empty
PI3Kα-IN-7 (Compound A12) is a potent inhibitor of PI3Kα and PI3Kβ, capable of reducing mitochondrial membrane potential in cancer cells and inducing apoptosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | PI3Kα-IN-7 (Compound A12) is a potent inhibitor of PI3Kα and PI3Kβ, capable of reducing mitochondrial membrane potential in cancer cells and inducing apoptosis. |
In vitro | PI3Kα-IN-7 (Compound A12) exhibits strong anti-tumor activity across multiple cell lines, including HCT116, PC-3, MCF-7, A549, and MDA-MB-231, with respective IC50 values of 3.24 μM, 14.37 μM, 7.39 μM, 7.10 μM, and 16.85 μM [1]. |
Molecular Weight | 402.47 |
Formula | C17H22N8O2S |
Cas No. | 2417098-53-2 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.